Elastomeric Infusion Pump Market Size, Share & Trends Analysis Report By Product (Continuous Rate Elastomeric Infusion Pumps, Variable Rate Elastomeric Infusion Pumps), By Application (Pain Management, Chemotherapy, Antibiotic/Antiviral Therapy, Other Applications), By End Use (Hospitals, Ambulatory Surgical Centers, Other End Uses) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Elastomeric Infusion Pump Market Size

The global elastomer infusion pump market size was valued at USD 688.38 million in 2025 and is projected to grow from USD 714.61 million in 2026 to USD 963.79 million by 2034, registering a CAGR of 3.81% during the forecast period from 2026 to 2034. North America dominated the elastomer infusion pump market with a market share of 39.73% in 2025.

The elastomeric infusion pump market is witnessing steady expansion driven by the rising shift toward home-based and ambulatory infusion therapies, particularly in oncology, antibiotic administration, and postoperative pain management. Increasing adoption of disposable, non-electronic delivery systems is being fueled by demand for infection control, reduced hospital stay duration, and cost-efficient drug administration models. The elastomeric infusion pump market growth is further supported by advancements in flow-control accuracy, temperature-stable elastomeric reservoirs, and prefilled drug compatibility designed for high-risk therapeutic areas. Expansion of hospital-at-home programs and decentralized care pathways is accelerating utilization across both developed and emerging healthcare systems. Strategic procurement by healthcare providers focusing on low-maintenance infusion solutions is reinforcing long-term adoption, positioning elastomeric pumps as a key component in simplified, patient-centric infusion care ecosystems globally.

Elastomeric Infusion Pump Market Segmentation Analysis

By Product

The continuous rate elastomeric infusion pumps segment is expected to grow at a CAGR of 4.36% during the forecast period. The growth is driven by increasing use in prolonged local anesthetic nerve block therapies requiring uninterrupted basal flow delivery. Rising preference for fixed-flow disposable systems in standardized chemotherapy dosing protocols also supports demand. Simplified clinician training requirements enhance adoption across high-patient-volume outpatient infusion settings.

The variable rate elastomeric infusion pumps segment is expected to grow at a CAGR of 5.92% during the forecast period. Variable rate elastomeric pumps are increasingly adopted in postoperative recovery and long-duration symptom management therapies where fixed-flow systems restrict treatment flexibility. Their customized infusion pacing capability improves suitability across specialized outpatient and home-based care settings.

Request Customizationto receive a tailored report.

By Application

Pain management dominated the application segment with a share of 36.11% in 2025 due to the increasing use of continuous local anesthetic infusions following minimally invasive orthopedic procedures. Rising adoption of opioid-sparing recovery protocols also accelerated demand. Elastomeric pumps support silent, mobility-friendly analgesic delivery, improving patient comfort during ambulatory postoperative rehabilitation and home recovery.

The antibiotic/antiviral therapy segment is expected to have the fastest growth, registering a CAGR of 5.64% during the forecast period due to rising continuous infusion use for time-dependent antimicrobials requiring stable plasma exposure. Increasing outpatient management of multidrug-resistant infections also supports adoption. Elastomeric pumps improve mobility and reduce repeated hospital-based intravenous administration requirements.

By End Use

In 2025, hospitals accounted for the largest share of 43.20% of the elastomeric infusion pump market, by end use. This dominance is attributed to reliance on hospital sterile compounding pharmacies for preparing patient-specific infusion-ready drugs requiring immediate administration under controlled conditions. It is also driven by extensive use in oncology inpatient wards where chemotherapy protocols demand supervised dosing adjustments and adverse-event monitoring. Post-surgical recovery units widely deploy elastomeric pumps for continuous analgesia delivery, requiring real-time clinical oversight and rapid intervention capability.

The ambulatory surgical centers segment is expected to grow at a CAGR of 6.03% during the forecast period, fueled by the adoption of same-day discharge surgical pathways, allowing effective post-procedure analgesia without hospital admission. Growing preference for minimally invasive surgeries is driving use of portable elastomeric infusion systems for controlled pain management. Expanding integration of outpatient pharmacy-prepared infusion kits improves perioperative workflow efficiency and patient throughput in ambulatory surgical centers.

Speak to an Analystto discuss market opportunities.

Regional Analysis

North America: Market Leadership through Increasing Use of Disposable Infusion Systems and Growing Adoption in Tribal Healthcare Facilities

The North America elastomeric infusion pump market accounted for a share of 39.73% in 2025 due to increasing use of disposable infusion systems in US correctional healthcare networks, where portable, tamper-resistant drug delivery is prioritized. Growing adoption within Native American tribal healthcare facilities and remote Canadian community care programs also supports demand due to limited access to electronic infusion infrastructure. Expanding use of elastomeric pumps in US clinical trial-based home infusion protocols is accelerating specialized outpatient deployment across precision oncology research programs.

The elastomeric infusion pump market in the US is growing due to increasing adoption of disposable infusion systems in federally funded rural health outreach programs, rising utilization in mobile chemotherapy services across underserved states, and expanding demand from concierge home-infusion providers offering premium outpatient biologic administration. Stricter cybersecurity concerns surrounding connected medical devices are encouraging certain healthcare facilities to prefer non-electronic elastomeric systems for low-risk continuous infusion therapies and decentralized specialty treatment environments.

Canada’s elastomeric infusion pump market is supported by increasing deployment of infusion therapy services through provincially managed pharmacist-led care models in Quebec and British Columbia. Rising adoption within Canadian palliative home-care networks for end-of-life analgesic administration is also expanding demand. Additionally, bilingual medical packaging and Health Canada’s stringent labeling compliance requirements are encouraging the development of customized elastomeric infusion systems tailored specifically for Canadian regulatory and healthcare distribution environments. These factors collectively drive market growth in Canada.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific: Fastest Growth Driven by Expanding Contract Manufacturing and Growing Integration with Fertility Tourism Clinics

The Asia Pacific elastomeric infusion pump market is expected to register the fastest regional growth with a CAGR of 6.71% during the forecast period, driven by increasing adoption of chemotherapy day-care centers in Japan and rising demand for battery-independent infusion devices across island-based healthcare networks in Indonesia and the Philippines. Expanding government-supported domestic medical device localization initiatives in China and India also supports market expansion. Overcrowded tertiary hospitals across major Asian cities are accelerating transition toward short-duration ambulatory infusion treatment models using disposable elastomeric systems.

China’s elastomeric infusion pump market expansion is led by increasing adoption of infusion therapy within “shared hospital bed” programs that transfer stabilized patients from tertiary hospitals to affiliated community centers using portable disposable pumps. Rising utilization in high-altitude western provinces, where simpler non-electronic infusion systems perform more reliably under unstable infrastructure conditions, further supports demand. China’s rapidly expanding contract manufacturing ecosystem enables OEM production of customized elastomeric pumps for domestic provincial tenders and export-focused Asian medical device supply chains.

The Thailand elastomeric infusion pump market is supported by increasing adoption of infusion systems within fertility tourism clinics supporting hormone and postoperative therapies, rising utilization across private Buddhist monastic healthcare foundations managing chronic pain treatment, and growing demand from island-based healthcare facilities in Phuket and Koh Samui requiring portable infusion solutions for tourist emergency care. Thailand’s strong cosmetic surgery recovery ecosystem is accelerating outpatient analgesic infusion use in premium aesthetic treatment centers.

Competitive Landscape

The elastomeric infusion pump market landscape is moderately consolidated and led by major global medical device companies such as Baxter International, B. Braun, Fresenius Kabi, and Smiths Group. These players dominate through broad product portfolios, reliable drug delivery systems, and strong hospital relationships. They focus on disposable pumps, home-care solutions, and improved flow control technologies. Mid-sized firms and regional manufacturers compete by offering low-cost devices and customized designs for oncology and pain management. Companies are increasing partnerships with healthcare providers and expanding distribution in emerging markets, while innovation in safety, portability, and patient-friendly designs continues to shape competition and market growth.

List of Key and Emerging Players in Elastomeric Infusion Pump Market